admin

Investors were already selling Skillz (NYSE:SKLZ) stock before the company posted quarterly earnings results on Aug. 3. Source: Rawpixel.com/Shutterstock.com After the report, SKLZ stock slumped further. Clearly there is something the market does not like about this electronic gaming and multimedia firm. At these levels, investors might think the stock has less risk and more
0 Comments
Support.com (NASDAQ:SPRT) holds its special meeting on Sept. 10 to vote on its merger with Greenridge Generation Holdings. The merger’s acceptance requires that more than 50% of owners of SPRT stock vote to approve the deal. Source: Shutterstock.com The two parties announced their merger on March 22. The day before the merger announcement, SPRT closed
0 Comments
Oil prices pushed past $70 for the first time in a month in late-day trading Thursday. The rally is breathing new life into the energy sector, which is up 2.5% at this writing. For the past quarter, energy stocks have been lagging the broader market, so shareholders are cheering the newfound strength. To celebrate the
0 Comments
When the Bank of Japan (BOJ) announced a policy of negative interest rates in 2016 by charging interest on reserve deposits, yields on Japanese government debt fell precipitously. The yield on 10-year Japanese government bonds fell to a record negative 0.135%, below the BOJ’s negative 0.1% reserve deposit rate. With the BOJ purchasing government bonds at an unprecedented annual rate
0 Comments
A leader in the online sports gambling industry, DraftKings (NASDAQ:DKNG) is expanding its presence across the States and is expected to benefit from the upcoming football season. The company is making well-timed moves to build new offerings and achieve growth. It has successfully partnered with some of the top sports companies to offer a unique experience
0 Comments
Have you seen gene editing and sequencing stocks recently? Source: Connect world / Shutterstock.com Illumina (NASDAQ:ILMN) is up 20% over the past three months. Beam Therapeutics (NASDAQ:BEAM) is up 45%. Editas Medicine (NASDAQ:EDIT) is up 90%. Intellia Therapeutics (NASDAQ:NTLA) is up 150%. Folks, the Genomic Revolution is here. And while everyone can see those big
0 Comments
Brian Hamilton gives us two growth and income stocks for 2018. Triton International: https://www.zacks.com/stock/quote/TRTN?cid=CS-YOUTUBE-FT-VID KLA Tencor: https://www.zacks.com/stock/quote/KLAC?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments